dr. Moulid Hidayat, Ph.D.

NUPTK: 5451764665130170
Pulmonologi Dan Kedokteran Respirasi (50.124.1066) Linked Authors: 3
3
H index
74
Cite

Personal Profile

Expertise related to UN Sustainable Development Goals

This person's work contributes towards the following SDG(s):

Good health and well-being
Research Output
19
Total Citations
74
Linked Authors
3
Top Concepts
Public Health and Nutrition
9 papers
score 0.85
COVID-19 Prevention and Impact
5 papers
score 0.85
Long-Term Effects of COVID-19
3 papers
score 0.99
COVID-19 Clinical Research Studies
2 papers
score 1.00
Healthcare Quality and Satisfaction
2 papers
score 0.88
Myasthenia Gravis and Thymoma
2 papers
score 0.58
Linked Authors
Moulid Hidayat 19 papers
Moulid Hidayat 0 papers
Moulid Hidayat 0 papers
See Also
Lihat semua dosen Lihat semua paper
Research output (19)
Challenges on tuberculosis care in health care facilities during COVID-19 pandemic: Indonesian perspective
https://doi.org/10.52225/narra.v2i2.80
Source: Narra J
Authors: Wira Winardi; Mohamad Yusup; Hendra Wahyuni; Moulid Hidayat; Aditya Wirawan et al.
article cite 20 Year 2022 Open Access
Accuracy of Volatile Organic Compound (VOC) Detection in Exhaled Breath Compared to Reverse-transcriptase Polymerase Chain Reaction (RT-PCR) for Diagnosis of COVID-19: An Evidence-based Case Report
https://doi.org/10.5812/archcid-119263
Source: Archives of Clinical Infectious Diseases
Authors: Agus Dwi Susanto; Moulid Hidayat; Heidy Agustin; Muhammad Taufik; Mohammad Azizur Rahman
article cite 1 Year 2022 Open Access
Hubungan Kadar D-dimer dan C-Reactive Protein terhadap Berat Gejala pada Pasien COVID-19
https://doi.org/10.29303/jku.v11i4.864
Source: Unram Medical Journal
Authors: Sang Ayu Nyoman Putri Pradnyasari; Prima Belia Fathana; Moulid Hidayat
article cite 0 Year 2022 Open Access
Hubungan Kadar D-dimer dan C-Reactive Protein terhadap Berat Gejala pada Pasien COVID-19
https://doi.org/10.29303/jk.v11i4.4765
Source: Unram Medical Journal
Authors: Sang Ayu Nyoman Putri Pradnyasari; Prima Belia Fathana; Moulid Hidayat
article cite 0 Year 2022 Open Access
Hyperinflammation Syndrome in COVID-19 Disease: Pathogenesis and Potential Immunomodulatory Agents
https://doi.org/10.5222/tji.2021.92486
Source: Turkish Journal of Immunology
Authors: Moulid Hidayat; Sita Andarini; Diah Handayani; Fariz Nurwidya
article cite 3 Year 2021 Open Access
PELATIHAN TERAPI OKSIGEN PADA TENAGA KESEHATAN DI RUMAH SAKIT UMUM UNIVERSITAS MATARAM
https://doi.org/10.29303/abdiinsani.v8i3.442
Source: Abdi Insani
Authors: Moulid Hidayat; Wahyu Sulistya Affarah; Prima Belia Fathana; Devi Ramadhona
article cite 1 Year 2021 Open Access
INTERLEUKIN-6 DAN POTENSI TERAPI INHIBISI INTERLEUKIN-6 DALAM TATA LAKSANA COVID-19
https://doi.org/10.29303/jku.v10i3.595
Source: Unram Medical Journal
Authors: Fariz Nurwidya; Moulid Hidayat; Itsna Arifatuz Zulfiyah
article cite 1 Year 2021 Open Access
Lung Fibrosis Sequelae After Recovery from COVID-19 Infection
https://doi.org/10.3855/jidc.13686
Source: The Journal of Infection in Developing Countries
Authors: Agus Dwi Susanto; Moulid Hidayat; Paulus Arka Triyoga; Fathiyah Isbaniah; Aulya Fairuz et al.
article cite 12 Year 2021 Open Access
The use of indoor plant as an alternative strategy to improve indoor air quality in Indonesia
https://doi.org/10.1515/reveh-2020-0062
Source: Reviews on Environmental Health
Authors: Agus Dwi Susanto; Aditya Wirawan; Wira Winardi; Moulid Hidayat
review cite 34 Year 2020 Open Access
Patent

Belum ada paten terkait dosen ini.